Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q4 FY22 results · Jan–Mar 2022
Abbott India reported revenue from operations of ₹1,255.02 crore (up 14.6% from Q4 FY21) and net profit of ₹211.41 crore (up 38.7% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a standalone basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,255.02 | 1,095.54 | +14.6% | 1,224.36 | +2.5% |
| Other income | 21.05 | 16.20 | +29.9% | 18.74 | +12.3% |
| Total income | 1,276.07 | 1,111.74 | +14.8% | 1,243.10 | +2.7% |
| Profit before tax | 292.30 | 201.88 | +44.8% | 266.65 | +9.6% |
| Net profit for the period | 211.41 | 152.47 | +38.7% | 199.20 | +6.1% |
| EPS, basic (₹) | 99.49 | 71.75 | +38.7% | 93.74 | +6.1% |
| Net margin (%) | 16.8 | 13.9 | 16.3 |
Standalone
- Filed with BSE
- 17 May 2022, 17:12 IST
- Board meeting
- 17 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE